Literature DB >> 16239349

Creating oral squamous cancer cells: a cellular model of oral-esophageal carcinogenesis.

Gitta Goessel1, Michael Quante, William C Hahn, Hideki Harada, Steffen Heeg, Yasir Suliman, Michaela Doebele, Alexander von Werder, Christine Fulda, Hiroshi Nakagawa, Anil K Rustgi, Hubert E Blum, Oliver G Opitz.   

Abstract

Immortalization and malignant transformation are important steps in tumor development. The ability to induce these processes from normal human epithelial cells with genetic alterations frequently found in the corresponding human cancer would significantly enhance our understanding of tumor development. Alterations in several key intracellular regulatory pathways (the pRB, p53, and mitogenic signaling pathways and the telomere maintenance system) appear to be sufficient for the neoplastic transformation of normal human cells. Nevertheless, in vitro transformation models to date depend on viral oncogenes, most prominently the simian virus 40 early region, to induce immortalization and malignant transformation of normal human epithelial cells. Here, we demonstrate a transformation model creating oral-esophageal cancer cells by using a limited set of genetic alterations frequently observed in the corresponding human cancer. In a stepwise model, cyclin D1 overexpression and p53 inactivation led to immortalization of oral keratinocytes. Additional ectopic epithelial growth factor receptor overexpression followed by c-myc overexpression as well as consecutive reactivation of telomerase induced by epithelial growth factor receptor sufficed to transform oral epithelial cells, truly recapitulating the development of the corresponding human disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16239349      PMCID: PMC1266078          DOI: 10.1073/pnas.0409730102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  52 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

Review 2.  The role of the SV40 ST antigen in cell growth promotion and transformation.

Authors:  K Rundell; R Parakati
Journal:  Semin Cancer Biol       Date:  2001-02       Impact factor: 15.707

3.  Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells.

Authors:  B Elenbaas; L Spirio; F Koerner; M D Fleming; D B Zimonjic; J L Donaher; N C Popescu; W C Hahn; R A Weinberg
Journal:  Genes Dev       Date:  2001-01-01       Impact factor: 11.361

Review 4.  Cellular transformation by SV40 large T antigen: interaction with host proteins.

Authors:  S H Ali; J A DeCaprio
Journal:  Semin Cancer Biol       Date:  2001-02       Impact factor: 15.707

Review 5.  The role of senescence and immortalization in carcinogenesis.

Authors:  R R Reddel
Journal:  Carcinogenesis       Date:  2000-03       Impact factor: 4.944

6.  Akt/protein kinase B isoforms are differentially regulated by epidermal growth factor stimulation.

Authors:  J Okano; I Gaslightwala; M J Birnbaum; A K Rustgi; H Nakagawa
Journal:  J Biol Chem       Date:  2000-10-06       Impact factor: 5.157

7.  Human cyclin D1 oncogene and esophageal squamous cell carcinoma.

Authors:  H Nakagawa; L Zukerberg; K Togawa; S J Meltzer; T Nishihara; A K Rustgi
Journal:  Cancer       Date:  1995-08-15       Impact factor: 6.860

Review 8.  Genetic steps in the development of squamous cell carcinoma of the esophagus.

Authors:  A M Mandard; P Hainaut; M Hollstein
Journal:  Mutat Res       Date:  2000-04       Impact factor: 2.433

9.  Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer.

Authors:  J R Grandis; D J Tweardy
Journal:  Cancer Res       Date:  1993-08-01       Impact factor: 12.701

10.  Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer.

Authors:  J Bartkova; J Lukas; H Müller; M Strauss; B Gusterson; J Bartek
Journal:  Cancer Res       Date:  1995-02-15       Impact factor: 12.701

View more
  17 in total

1.  Cervical keratinocytes containing stably replicating extrachromosomal HPV-16 are refractory to transformation by oncogenic H-Ras.

Authors:  Kristi L Berger; Felicia Barriga; Michael J Lace; Lubomir P Turek; Gideon J Zamba; Frederick E Domann; John H Lee; Aloysius J Klingelhutz
Journal:  Virology       Date:  2006-08-30       Impact factor: 3.616

2.  Phase II trial of post-operative radiotherapy with concurrent cisplatin plus panitumumab in patients with high-risk, resected head and neck cancer.

Authors:  R L Ferris; J L Geiger; S Trivedi; N C Schmitt; D E Heron; J T Johnson; S Kim; U Duvvuri; D A Clump; J E Bauman; J P Ohr; W E Gooding; A Argiris
Journal:  Ann Oncol       Date:  2016-10-11       Impact factor: 32.976

Review 3.  Reviewing once more the c-myc and Ras collaboration: converging at the cyclin D1-CDK4 complex and challenging basic concepts of cancer biology.

Authors:  Chenguang Wang; Michael P Lisanti; D Joshua Liao
Journal:  Cell Cycle       Date:  2011-01-01       Impact factor: 4.534

4.  Loss of transcription factor KLF5 in the context of p53 ablation drives invasive progression of human squamous cell cancer.

Authors:  Yizeng Yang; Hiroshi Nakagawa; Marie-Pier Tetreault; Janelle Billig; Noel Victor; Abha Goyal; Antonia R Sepulveda; Jonathan P Katz
Journal:  Cancer Res       Date:  2011-08-25       Impact factor: 12.701

5.  Phase II trial of everolimus in patients with previously treated recurrent or metastatic head and neck squamous cell carcinoma.

Authors:  Jessica L Geiger; Julie E Bauman; Michael K Gibson; William E Gooding; Prakash Varadarajan; Athanasios Kotsakis; Daniel Martin; Jorge Silvio Gutkind; Matthew L Hedberg; Jennifer R Grandis; Athanassios Argiris
Journal:  Head Neck       Date:  2016-05-27       Impact factor: 3.147

Review 6.  The molecular biology of head and neck cancer.

Authors:  C René Leemans; Boudewijn J M Braakhuis; Ruud H Brakenhoff
Journal:  Nat Rev Cancer       Date:  2010-12-16       Impact factor: 60.716

7.  A phase II study of temsirolimus and erlotinib in patients with recurrent and/or metastatic, platinum-refractory head and neck squamous cell carcinoma.

Authors:  Julie E Bauman; Hugo Arias-Pulido; Sang-Joon Lee; M Houman Fekrazad; Hiroyuki Ozawa; Elana Fertig; Jason Howard; Justin Bishop; Hao Wang; Garth T Olson; Michael J Spafford; Dennie V Jones; Christine H Chung
Journal:  Oral Oncol       Date:  2013-02-04       Impact factor: 5.337

Review 8.  Inflammation and stem cells in gastrointestinal carcinogenesis.

Authors:  Michael Quante; Timothy Cragin Wang
Journal:  Physiology (Bethesda)       Date:  2008-12

9.  Immortalization of normal human gingival keratinocytes and cytological and cytogenetic characterization of the cells.

Authors:  Chikahiro Kubo; Takeo W Tsutsui; Yukiko Tamura; Shin-Ichi Kumakura; Takeki Tsutsui
Journal:  Odontology       Date:  2009-01-29       Impact factor: 2.634

10.  Over-expression of c-Myc oncoprotein in oral squamous cell carcinoma in the South Indian population.

Authors:  Rb Pai; Sb Pai; Rm Lalitha; Sv Kumaraswamy; N Lalitha; Rn Johnston; M Bhargava
Journal:  Ecancermedicalscience       Date:  2009-02-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.